home / stock / vrtx / vrtx articles

VRTX Articles, Vertex Pharmaceuticals Incorporated

Stock Information
Company Name: Vertex Pharmaceuticals Incorporated
Stock Symbol: VRTX
Market: NASDAQ
Menu
VRTX VRTX Quote VRTX Short VRTX News VRTX Articles VRTX Message Board
Get VRTX Alerts

News, Short Squeeze, Breakout and More Instantly...
Pfizer, Freeport-McMoRan, Vertex Pharmaceuticals And A Major Tech Stock On CNBC's 'Final Trades' | Benzinga

On CNBC's “Halftime Report Final Trades,” Joshua Brown of Ritholtz Wealth Management said under $30, Pfizer Inc. (NYSE:PFE) is a g...
Here's How Much You Would Have Made Owning Vertex Pharmaceuticals Stock In The Last 10 Years | Benzinga

Vertex Pharmaceuticals (NASDAQ:VRTX) has outperformed the market over the past 10 years by 9.66% on an annualized basis producing an average annual...

VERTEX AND TREEFROG THERAPEUTICS ANNOUNCE LICENSING AGREEMENT AND COLLABORATION TO OPTIMIZE PRODUCTION OF VERTEX'S CELL THERAPIES FOR TYPE 1 DIABETES | Benzinga

Vertex obtains an exclusive license to TreeFrog's C-StemTM  manufacturing technology in type 1 diabetes  TreeFrog and Vertex to collaborate...

Tesla To $123? Here Are 10 Top Analyst Forecasts For Thursday | Benzinga

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgr...
If You Invested $1000 In This Stock 10 Years Ago, You Would Have $6,000 Today | Benzinga

Vertex Pharmaceuticals (NASDAQ:VRTX) has outperformed the market over the past 10 years by 8.81% on an annualized basis producing an average annual...

Vertex's Alpine Acquisition: Unpacking Analyst Predictions on Povetacicept's Potential Impact | Benzinga

On Wednesday, Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) agreed to acquire Alpine Immune Sciences Inc (NASDAQ:ALPN) for ...

Vertex Pharmaceutical's Move Beyond Its $10B Cystic Fibrosis Franchise, Pays Around $5B For Kidney Disease Player Alpine Immune | Benzinga

On Wednesday, Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) agreed to acquire Alpine Immune Sciences Inc (NASDAQ:ALPN) for ...
Vertex Pharmaceuticals Moves Beyond $10B Cystic Fibrosis Franchise, Pays Around $5B For Kidney Disease Player Alpine Immune | Benzinga

On Wednesday, Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) agreed to acquire Alpine Immune Sciences Inc (NASDAQ:ALPN) for ...

Wall Street Braces For Another Red Day Ahead Of More Inflation Data While Bitcoin Holds Above $70K: Analyst Sees Any Pullback As 'Phenomenal Buying Opportunity' | Benzinga

The negative mood on Wall Street may persist as investors await the release of another inflation report, which will have significant implications f...

Jim Cramer Was Upset At This Hostile Takeover, But 'They Fixed The Situation. Stock's Been A Horse' | Benzinga

On CNBC’s "Mad Money Lightning Round," Jim Cramer said he prefers Abbott Laboratories (NYSE: ABT) over Penumbra, Inc. (NYSE: PE...
Next 10